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Introduction
Diabetic nephropathy (DN) is one of the most severe and common chronic complications of diabetes mellitus (DM) [1] . The principal pathological changes associated with DN include glomerular extracellular matrix (ECM) accumulation, glomerular hypertrophy, glomerular basement membrane (GBM) thickening and glomerulosclerosis, which may devolve into stage renal disease (ESRD) [1, 2] . Multiple mechanisms, including dyslipidemia, hyperglycemia, hemodynamic abnormalities, oxidative stress and autophagy, contribute to DN initiation and progression, eventually leading to ESRD [1, 3] . These morphological changes in the renal glomeruli are ultimately derived from excess or inappropriate activation of the renin-angiotensin system (RAS), a well-known endocrine balance [4] . Growing evidence has revealed that there is local RAS in the kidney, which can affect cellular activity and tissue injury [5] , and the classical renin/angiotensin I-converting enzyme (ACE)/angiotensin II (Ang II)/Ang II type 1 receptor (AT1R) axis of RAS is a critical pathway leading to ESRD [6, 7] . In addition, AT1R plays an important role in regulating renal renal cells and surrounding cells. Every known component of RAS is contained within mesangial cells (MCs). We have previously found that Ang II/AT1R can induce ECM accu-mulation and cell proliferation in rat renal MCs [8] . Ang II also which plays a central role in driving renal fibrosis and DN through Smad3 signaling [9] [10] [11] [12] . It has been demonstrated that ACE inhibitors (ACEI) and AT1R blockers (ARB) have sigpatients, renal fibrosis of experimental murine models and dysfunction of cultured MCs [13] [14] [15] [16] . SND p102 is a rat homologue of human staphylococcal nuclease and tudor domain-containing 1 (SND1), first described as an Epstein-Barr virus nuclear antigen 2 (EBNA 2) co-activator [17] [18] [19] . SND1, also known as Tudor staphylococcal nuclease (Tudor-SN) or p100 protein, is a multifunctional protein that regulates various intracellular processes, such as transcriptional activation, RNA interference, mRNA splicing, editing, and stability, protein ubiquitination and proteasomal degradation [20] [21] [22] . We have previously demonstrated that SND p102 is increased in MCs under hyperglycemic conditions and is potentially involved in ECM accumulation in MCs. However, the mechanism by which SND p102 participates in high glucose (HG)-induced MC activation remains unclear.
It has been previously demonstrated that Ang II can directly -ing pathway [23] . In the present study, we investigated whether SND p102 overexpression or knockdown could directly affect ECM accumulation and proliferation in MCs and whether involved in SND p102-induced cell dysfunction.
Materials and methods

Cell culture
The rat mesangial cell line HBZY-1 was purchased from the Center of Type Culture Collection (Wuhan, China) and cultured in normal glucose (NG) DMEM medium (5.5 mmol/L D an atmosphere of 5% CO 2 at 37 °C. 293T cells were kindly pro--ated by supplementing normal DMEM medium with additional D-glucose at a final concentration of 25 mmol/L. An osmotic control medium was generated by supplementing normal medium with 19.5 mmol/L mannitol.
Isolation and culture of rat renal glomeruli Sprague Dawley rats (180-200 g) were obtained from Shanghai SLAC Laboratory Animal Co Ltd (Shanghai, China). All experimental procedures followed the Criteria of the Medical Laboratory Animal Administrative Committee of Shanghai and the Guide for the Care and Use of Laboratory Animals of University. Glomeruli were isolated from euthanized SD rats as described previously [24] by gentle grinding of the renal cortex fragments on a 200-mm -trates through sieves with mesh sizes of 150, 100, and 75 mm.
The glomeruli were then collected and cultured in NG DMEM atmosphere of 5% CO 2 at 37°C. High-glucose (HG) culture medium was generated by supplementing normal DMEM medium with additional D 25 mmol/L.
Animal model
Male Sprague-Dawley rats, weighing 180-210 g, were provided by the Shanghai SLAC Laboratory Animal Center. All experimental procedures followed the Criteria of the Medical Laboratory Animal Administrative Committee of Shanghai and the Guide for the Care and Use of Laboratory Animals -mittee for Experimental Research, Shanghai Medical College, intraperitoneal injection of STZ (50 mg/kg) dissolved in 0.1 mol/L sodium citrate buffer (pH 4.0). Only animals with plasma glucose concentrations >16.7 mmol/L one week after STZ injection were included in the study, as described previously [25] . Twelve weeks after STZ injection, rats were euthanized, kidney tissues were collected, and the renal cortex was dissected and used for Western blot analyses.
Plasmids, siRNA and cell transfection A plasmid expressing full-length SND p102, called pcDNA3.0-SND p102, and a rat AT1R 3'-untranslated region (3'-UTR)-luciferase reporter construct were obtained from TaiHe Biotechnology Co, Ltd. Rat SND p102 siRNA and AT1R siRNA were purchased from the Ribobio Company (Guangzhou, Guangdong, China). The sequences used were as follows: SND --TACGAAAATGAG-3', R5'-TAGATCCTG AGGCAGGGT-GAAT-3'). A nonsilencing siRNA oligonucleotide (Ribobio, Guangzhou, China) was used as a negative control. Cells were -using Lipofectamine 2000 Reagent (Invitrogen) according to -tion, cells were harvested for immunoblotting analysis, realtime PCR and luciferase assays.
Real-time PCR analysis
Total RNA was extracted from kidney tissues using TRIzol ® (Invitrogen), and AT1R mRNA was measured by real-time PCR, as described previously [23] . The housekeeping gene levels of AT1R.
Western blotting and antibodies
Cell lysates and renal cortex tissue homogenates were prepared as previously described [26] . The antibodies used were as follows: anti-SND p102, anti-collagen IV, anti-AT1R, anti-(Sigma, St. Louis, MO, USA).
Cell proliferation assay
MCs in the logarithmic growth phase were seeded in 96-well plates at a cell density of 2000 cells/well. After HG treatment or transfection with siRNAs or plasmids for 48 or 72 h, cell proliferation was measured by 5-bromo-2'-deoxyuridine (BrdU) incorporation assay (Roche, Mannheim, Germany) according to the manufacturer's instructions, as described previously [25] .
Luciferase assay of the 3'-UTR of AT1R 293T cells were seeded at 5×10 4 well in a 24-well plate (37 °C, 5% CO 2 ). After 18 to 24 h of pmir-GLO Dual-Luciferase miRNA Target Expression Vector) containing the 3'-UTR of AT1R or control luciferase reporter plasthe renilla luciferase gene (Promega) were cotransfected with 200 ng of pcDNA3.0-SND p102 plasmid or pcDNA3.0 plasmid using Lipofectamine 2000 (Invitrogen). Luciferase activity was measured using the Dual-Luciferase reporter assay system (Promega) according to the manufacturer's instructions.
activity.
Statistical analysis
Numerical data are presented as the mean±SEM from at least three independent experiments and compared by Student's t test or one-way ANOVA using SPSS 17.0 software. P<0.05 values.
Results
SND p102 expression is up-regulated in diabetic kidneys and HGtreated glomeruli and MCs 1A). To determine the relevance of SND p102 expression in DN, we measured SND p102 expression in diabetic kidneys and glomeruli cultured in HG medium. SND p102 was weakly expressed in normal kidneys and glomeruli but highly expressed in diabetic kidneys and glomeruli cultured in HG In cultured MCs, we found that HG significantly induced and collagen IV protein expression, as shown by Western blot 
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* P ** P 2B). These pathologic changes were similarly accompanied by SND p102 regulates ECM production and proliferation in cultured MCs To evaluate potential regulation of ECM production and proliferation of MCs by differential SND p102 expression, the recombinant plasmid pcDNA3.0-SND p102, containing fulllength SND p102 cDNA, and SND p102 siRNA were used to overexpress or silence SND p102. A significant increase in SND p102 protein levels was observed in MCs transfected ---regulation of ECM production and the proliferation of MCs.
SND p102 regulates AT1R expression in cultured MCs
The excessive activation of intrarenal RAS plays an important role in the pathogenesis of diabetic nephropathy. Western blot analysis showed that compared with pcDNA3.0, pcDNA3.0-SND p102 transfection significantly up-regulated AT1R
with SND p102 siRNA, but not control siRNA, significantly
Knockdown of AT1R expression blocks SND p102-induced ECM production and cell proliferation in cultured MCs AT1R siRNA treatment remarkably down-regulated SND This led to a reduction in cell proliferation and protein expres--
Knockdown of AT1R expression blocks SND p102-induced AT1R/ ERK/Smad3 activation in cultured MCs
As previous studies have demonstrated that Ang II can induce --tein kinase cross-signaling pathway [24] , we evaluated whether * P ** P Figure 6 .
* P ** P ## P --SND p102 enhances AT1R expression by increasing its mRNA levels via the AT1R 3'-UTR in cultured 293T cells As demonstrated by real-time PCR, AT1R was highly expressed at the mRNA level in 293T cells transfected with pcDNA3.0-SND p102 plasmid compared with cells transfected -ity of a direct targeting mechanism of SND p102 to the AT1R 3'-UTR, we performed a luciferase assay of the 3'-UTR of AT1R. A luciferase reporter plasmid containing the 3'-UTR of AT1R or a control reporter plasmid was cotransfected separately with pcDNA3.0-SND p102 plasmid or pcDNA3.0 plasmid. Luciferase activity was measured at 48 h post-transfection. Compared with the control samples, the luciferase activity of Luc (AT1R 3'-UTR) increased after SND p102 over-AT1R expression by increasing its mRNA levels via direct interactions with the AT1R 3'-UTR.
Discussion
Glomerulopathy, characterized by thickening of the GBM and mesangial cell expansion, is the most important renal structural change associated with DN. Morphological lesions develop concomitantly in the arterioles, tubules and interstitium [27] , and the pathogenic processes of glomerulopathy evenRenal MCs are important interstitial cells in glomeruli that play a crucial role in the maintenance of the normal morphology and function of glomeruli [28, 29] . Abnormalities in renal MCs will lead to functional and morphological changes in renal glomeruli.
Although the role of the ACE/Ang II/AT1R axis is well established in diabetic nephropathy, regulating functions of renal tubular epithelial cells, endothelial cells, podocytes and mesangial cells, the molecular mechanism underlying RAS dysfunction has not been clearly demonstrated [30, 31] . In the present study, we describe a novel molecular signaling pathway between SND p102 and AT1R with subsequent activation -tion and proliferation of rat MCs. * P ** P ## P of Epstein-Barr virus nuclear antigen 2 (EBNA-2) [17, 19] and subsequently determined to be a co-regulator of Pim-1 [32] , signal transducer and activator of transcription 6 (STAT6) [33] , and STAT5 [34] . We have previously reported that SND p102 expression is increased in HG-treated MCs and plays a role in the ECM accumulation of MCs by regulating the activation of RAS [23] . However, the underlying mechanisms remain to be further clarified. In this study, we also confirmed that SND p102 expression was remarkably increased in diabetic kidneys and glomeruli and MCs under hyperglycemic conditions, A major, novel finding in this study was the facilitating effect of SND p102 on AT1R expression and subsequent actidemonstrated that AT1R protein levels were increased in SND p102-overexpressing cells, without any addition of the natural AT1R ligand Ang II, and were decreased in SND p102-silenced cells. In addition, AT1R mRNA levels were also increased by SND p102. We also used luciferase reporter assays to further illustrate that the AT1R 3'-UTR is required for the regulation of AT1R expression by SND p102. Although it is challenging to determine whether the increased AT1R mRNA levels were due to enhanced mRNA stability or translation by luciferase assay, we have shown that SND p102 can mediate the progression of diabetic nephropathy by targeting the AT1R 3'-UTR. p102) can bind to the 3'-UTR of AT1R mRNA, resulting in increased AT1R expression by enhancing the stability of AT1R mRNA and translation by RNA-binding protein immunoprecipitation (RIP) assay, mRNA half-life analysis and in vitro translation, which further supports our present findings [35] . RNA electrophoretic mobility-shift assay (REMSA) was also used in that study to show that the AT1R 3'-UTR residues 118-120 are required for p100 binding. Thus, we propose that p100 can regulate AT1R mRNA levels by affecting the mRNA sta- [35] .
We also found that knockdown of AT1R could block SND -naling pathway, as well as ECM production and cell proliferation in MCs, indicating that the overexpression of AT1R led contributed to subsequent fibrotic changes. These findings
In the present study, we provide supportive evidence to indicate that HG can activate SND p102 expression, consequently enhancing the posttranscriptional activation of AT1R in which SND p102 recognizes and binds to the 3'-UTR of accumulation and proliferation of rat MCs. Our study demonstrates the role and underlying mechanism of SND p102 in regulating MC dysfunction and may suggest a novel therapeutic strategy for DN treatment.
